InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Southpoint Capital Advisors LP. Officer active across 1 company, notably Fennec Pharmaceuticals INC.. In total, 4 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €7.8m. Activity tracked since 7 October 2025. The latest transaction was disclosed on 24 December 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Southpoint Capital Advisors LP is a declarant linked to Fennec Pharmaceuticals INC. (XNAS). The 4 sampled filings, all sales, cover the period from 2025-10-09 to 2025-12-29, with EUR 7,827,129 in sales across this sample.